Jasper Therapeutics Stock Revenue
| JSPR Stock | USD 23.62 0.35 1.46% |
Jasper Therapeutics fundamentals help investors to digest information that contributes to Jasper Therapeutics' financial success or failures. It also enables traders to predict the movement of Jasper Stock. The fundamental analysis module provides a way to measure Jasper Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jasper Therapeutics stock.
| Last Reported | Projected for Next Year |
Jasper | Revenue |
Jasper Therapeutics Company Revenue Analysis
Jasper Therapeutics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Jasper
Projected quarterly revenue analysis of Jasper Therapeutics provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Jasper Therapeutics match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Jasper Therapeutics' stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Jasper Therapeutics reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Jasper Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jasper Therapeutics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jasper Therapeutics could also be used in its relative valuation, which is a method of valuing Jasper Therapeutics by comparing valuation metrics of similar companies.Jasper Therapeutics is currently under evaluation in revenue category among its peers.
Jasper Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Jasper Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Jasper Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Jasper Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Jasper Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Jasper Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Jasper Therapeutics' value.| Shares | Woodline Partners Lp | 2024-09-30 | 495.1 K | Braidwell Lp | 2024-09-30 | 483.3 K | Rock Springs Capital Management Lp | 2024-09-30 | 459.1 K | Great Point Partners Llc | 2024-06-30 | 402 K | Ally Bridge Group (ny) Llc | 2024-09-30 | 399.5 K | Opaleye Management Inc | 2024-09-30 | 353.5 K | Boxer Capital Llc | 2024-09-30 | 350 K | Integral Health Asset Management, Llc | 2024-09-30 | 350 K | Bank Of America Corp | 2024-06-30 | 325.3 K | Velan Capital Investment Management Lp | 2024-09-30 | 1.4 M | Soleus Capital Management, L.p. | 2024-09-30 | 1.3 M |
Jasper Fundamentals
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.41 | ||||
| Current Valuation | 269.15 M | ||||
| Shares Outstanding | 15 M | ||||
| Shares Owned By Insiders | 4.98 % | ||||
| Shares Owned By Institutions | 95.02 % | ||||
| Number Of Shares Shorted | 1.94 M | ||||
| Price To Book | 4.23 X | ||||
| EBITDA | (64.98 M) | ||||
| Net Income | (64.47 M) | ||||
| Cash And Equivalents | 60.81 M | ||||
| Cash Per Share | 1.60 X | ||||
| Total Debt | 2.79 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.56 X | ||||
| Book Value Per Share | 5.58 X | ||||
| Cash Flow From Operations | (52.07 M) | ||||
| Short Ratio | 6.10 X | ||||
| Earnings Per Share | (4.75) X | ||||
| Target Price | 69.5 | ||||
| Number Of Employees | 45 | ||||
| Beta | 2.2 | ||||
| Market Capitalization | 354.33 M | ||||
| Total Asset | 94.89 M | ||||
| Retained Earnings | (169.6 M) | ||||
| Working Capital | 76.56 M | ||||
| Net Asset | 94.89 M |
About Jasper Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jasper Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Jasper Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jasper Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Jasper Stock
| 0.47 | A | Agilent Technologies | PairCorr |
| 0.41 | ME | 23Andme Holding | PairCorr |
| 0.37 | DOMH | Dominari Holdings | PairCorr |
| 0.31 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Jasper Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jasper Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jasper Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jasper Therapeutics to buy it.
The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jasper Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jasper Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jasper Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.